The ROE as of December 2025 (TTM) for HBM Holdings Limited (HBMHF) is 18.28%

According to HBM Holdings Limited’s latest financial reports and current stock price. The company's current ROE is 18.28%. This represents a change of 132.18% compared to the average of 7.87% of the last 4 quarters.

HBM Holdings Limited (HBMHF) Historical ROE (quarterly & annually)

How has HBMHF ROE performed in the past?

The mean historical ROE of HBM Holdings Limited over the last ten years is -26.61%. The current 18.28% ROE has changed -168.70% with respect to the historical average. Over the past ten years (40 quarters), HBMHF's ROE was at its highest in in the June 2020 quarter at 23.98%. The ROE was at its lowest in in the December 2022 quarter at -69.13%.

HBM Holdings Limited (HBMHF) ROE by Quarter and Year

Discovering the peaks and valleys of HBM Holdings Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

HBM Holdings Limited (HBMHF) Average ROE

How has HBMHF ROE performed in the past?

The current ROE of HBM Holdings Limited (HBMHF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

HBM Holdings Limited (HBMHF) ROE vs. Peers

How is HBMHF’s ROE compared to its peers?

HBM Holdings Limited’s ROE is greater than Anebulo Pharmaceuticals, Inc. (-67.78%), greater than Rezolute, Inc. (-62.82%), less than HCW Biologics Inc. (507.82%), greater than Eliem Therapeutics, Inc. (-23.10%), greater than Molecular Partners AG (-50.31%), less than TRACON Pharmaceuticals, Inc. (90.15%), less than XOMA Royalty Corp. (22.30%), greater than Sio Gene Therapies Inc. (-78.26%), greater than Vincerx Pharma, Inc. (-308.66%), less than Virpax Pharmaceuticals, Inc. (460.78%), greater than Acurx Pharmaceuticals, Inc. (-219.56%), greater than MediciNova, Inc. (-23.12%), greater than NextCure, Inc. (-107.57%), greater than Entera Bio Ltd. (-16.70%), greater than Day One Biopharmaceuticals, Inc. (-32.05%), greater than Acumen Pharmaceuticals, Inc. (-97.41%), greater than X4 Pharmaceuticals, Inc. (-375.31%), greater than Inozyme Pharma, Inc. (-159.97%), greater than VectivBio Holding AG (-56.92%), less than Bio-Path Holdings, Inc. (478.10%), less than Endonovo Therapeutics, Inc. (9.10%), greater than Cingulate Inc. (-842.45%), greater than Purple Biotech Ltd. (-8.23%), greater than Soleno Therapeutics, Inc. (-25.88%),

Build a custom stock screener for HBM Holdings Limited (HBMHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HBM Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

HBM Holdings Limited (HBMHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like HBM Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.